HD10: Investigating reduction of combined modality treatment intensity in early stage Hodgkin's Lymphoma.  Interim analysis of a randomized trial of the German Hodgkin's Study Group (GHSG)

Reviewer: Ryan Smith , MD
OncoLink
Ultima Vez Modificado: 14 de mayo del 2005

Translation for this article does not exist

Blogs

Cancer and Hair Loss
by Bob Riter
February 11, 2016